Tuberculin reactivity in a population of schoolchildren with high BCG vaccination coverage

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 13, Issue 5, 2003, Pages 285-293

  Bierrenbach, Ana L ^a   Cunha, Sérgio S ^a   Barreto, Maurício L ^b   Pereira, Susan M ^b   Dourado, Inês ^b   Ichihara, Maria Y ^a,c   Brito, Silvana C ^b   Rodrigues, Laura C ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c FUNDAÇÃO NACIONAL DE SAÚDE   (Brazil)

Author keywords

BCG vaccine; Brazil; Immunization programs; Tuberculin test; Tuberculosis

Indexed keywords

BCG VACCINE;

VACCINATION;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; BACTERIAL TRANSMISSION; BCG VACCINATION; BRAZIL; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; SCHOOL CHILD; SEX DIFFERENCE; SKIN INDURATION; SKIN SCAR; TUBERCULIN TEST; TUBERCULOSIS;

EID: 0038513732     PISSN: 10204989     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1020-49892003000400003     Document Type: Article

References (49)

1. Lee E, Holzman RS. Evolution and current use of the tuberculin test. Clin Infect Dis 2002;34:365-370.
2. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999;282(7):677-686.
3. Arnadottir T, Rieder HL, Trebucq A, Waaler HT. Guidelines for conducting tuberculin skin test surveys in high prevalence countries. Tuber Lung Dis 1996;77(suppl 1):1-19.
4. Menzies R, Vissandjee B. Effect of bacille Calmette-Guerin vaccination on tuberculin reactivity. Am Rev Respir Dis 1992;145(3):621-625.
5. Fine PEM, Floyd S, Stanford JL, As LC, Chaguluka S, Warndorff DK, et al. Environmental mycobacteria in Northern Malawi: implications for the epidemiology of tuberculosis and leprosy. Epidemiol Infection 2001;126:379-387.
6. Ruffino-Netto A, de Souza AM. Evolution of the health sector and tuberculosis control in Brazil. Rev Panam Salud Publica 2001;9(5):306-310.
7. Brasil, Ministério da Saúde do Brasil. Segundo informe técnico sobre vacinação/revacinação BCG. Brasilia: Ministério da Saúde; 1994.
8. Sterne JA, Rodrigues LC, Guedes IN. Does the efficacy of BCG decline with time since vaccination? Int J Tuberc Lung Dis 1998;2(3):200-207.
9. Global Tuberculosis Programme and Global Program on Vaccines. Statement on BCG revaccination for the prevention of tuberculosis. Wkly Epidemiol Rec 1995;70(32):229-231.
10. Barreto ML, Rodrigues LC, Cunha SS, Pereira S, Hijjar MA, Ichihara MY, et al. Design of the Brazilian BCG-REVAC trial against tuberculosis: a large, simple randomized community trial to evaluate the impact on tuberculosis of BCG revaccination at school age. Control Clin Trials 2002;23:540-553.
11. Brasil, Departamento de Informática do Sistema Único de Saúde. Indicadores e dados básicos de saúde 1998 [Internet site]. Available from: http://www.datasus.gov.br/cgi/idb98/matriz.htm. Accessed 10 October 2001.
12. Rieder HL. Methodological issues in the estimation of the tuberculosis problem from tuberculin surveys. Tuber Lung Dis 1995;76(2):114-121.
13. Borgdorff MW, Egwaga SM, Muwinge H, Kalisvaart NA, Nagelkerke NJD. Density of tuberculin skin reaction and its association with tuberculosis infection as defined by dual skin testing. Int J Tuber Lung Dis 2000;4(11):1060-1065.
14. Pereira SM, Dourado MI, Barreto ML, Cunha SS, Ichihara MY, Rodrigues LC. Sensitivity and specificity of BCG scar reading in Brazil. Int J Tuberc Lung Dis 2001;5(11):1067-1070.
15. Neuenschwander BE, Zwahlen M, Kim SJ, Engel RR, Rieder HL. Trends in the prevalence of infection with Mycobacterium tuberculosis in Korea from 1965 to 1995: an analysis of seven surveys by mixture models. Int J Tuber Lung Dis 2000;4:719-729.
16. Horwitz O, Bunch-Christensen K. Correlation between tuberculin sensitivity after 2 months and 5 years among BCG vaccinated subjects. Bull WHO 1972;47:49-58.
17. Baily GV. Tuberculosis prevention trial, Madras. Indian J Med Res 1980;72 Suppl:1-74.
18. Dawodu AH. Tuberculin conversion following BCG vaccination in preterm infants. Acta Paediatr Scand 1985;74(4):564-567.
19. Karalliedde S, Katugaha LP, Uragoda CG. Tuberculin response of Sri Lankan children after BCG vaccination at birth. Tubercle 1987;68:33-38.
20. Sedaghatian MR, Shana'a IA. Evaluation of BCG at birth in the United Arab Emirates. Tubercle 1990;71(3):177-180.
21. Aggarwal A, Dutta AK. Timing and dose of BCG vaccination in infants as assessed by postvaccination tuberculin sensitivity. Indian Pediatr 1995;32(6):635-639.
22. Ferreira AA, Bunn Moreno MM, Sant'Anna CC, Ferreira MF. BCG vaccination in low birth weight newborns: analysis of lymphocyte proliferation, IL-2 generation and intradermal reaction to PPD. Tuber Lung Dis 1996;77(5):476-481.
23. Hoft DF, Kemp EB, Marinaro M, Cruz O, Kiyono H, McGhee JR, et al. A double-blind, placebo-controlled study of Mycobacterium-specific human immune responses induced by intradermal bacille Calmette-Guerin vaccination. J Lab Clin Med 1999;134(3):244-252.
24. Black GF, Weir RE, Floyd S, Bliss L, Wamdorff DK, Crampin AC, et al. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet 2002;359(9315):1393-1401.
25. Aydinlioglu H, Caglayan S, Kansoy S, Yaprak I, Seckin E, Bakiler AR, et al. The decline of BCG immunity after neonatal vaccination: what about revaccination at one year? Paediatr Perinat Epidemiol 1993;7:334-348.
26. Fine PE, Bruce J, Ponnighaus JM, Nkhosa P, Harawa A, Vynnycky E. Tuberculin sensitivity: conversions and reversions in a rural African population. Int J Tuberc Lung Dis 1999;3(11):962-975.
27. Gloyd S, Lopez JL, Mercado FJ, Durning J. Riesgo de infección por Mycobacterium tuberculosis en Jalisco, México. Bol Oficina Sanit Panam 1991;111(5):393-401.
28. Larsson LO, Magnusson M, Skoogh BE, Lind A. Sensitivity to sensitins and tuberculin in Swedish children. IV. The influence of BCG-vaccination. Eur Respir J 1992;5(5):584-586.
29. Miret Cuadras P, Pina Gutierrez JM, Juncosa S. Tuberculin reactivity in Bacillus Calmette-Guerin vaccinated subjects. Tuber Lung Dis 1996;77(1):52-58.
30. Waddell RD, von Reyn CF, Baboo KS, Mwinga A, Chintu C, Zumla A. The effects of BCG immunization and human immunodeficiency virus infection on dual skin test reactions to purified protein derivative and Mycobacterium avium sensitin among adults in Zambia. Int J Tuberc Lung Dis 1999;3(3):255-260.
31. Bierrenbach AL, Cunha SS, Barreto ML, Pereira SM, Rodrigues LC. Skin test reactivity to mycobacterial antigens parallels the phylogenetical structure of their genus. Int J Tuberc Lung Dis 2001;5(7):656-663.
32. Young TK, Mirdad S. Determinants of tuberculin sensitivity in a child population covered by mass BCG vaccination. Tuber Lung Dis 1992;73(2):94-100.
33. Mudido PM, Guwatudde D, Nakakeeto MK, Bukenya GB, Nsamba D, Johnson JL, et al. The effect of bacille Calmette-Guerin vaccination at birth on tuberculin skin test reactivity in Ugandan children. Int J Tuberc Lung Dis 1999;3(10):891-895.
34. Johnson H, Lee B, Doherty E, Kelly E, McDonnell T. Tuberculin sensitivity and the BCG scar in tuberculosis contacts. Tuber Lung Dis 1995;76(2):122-125.
35. Rumisha D, Baratedi J, Chimidza N, Hirschfeld C, Reed M, Notha M, et al. Tuberculin skin test survey in a pediatric population with high BCG vaccination coverage - Botswana, 1996. MMWR Morb Mortal Wkly Rep 1997;46(36):846-851.
36. Lockman S, Tappero JW, Kenyon TA, Rumisha D, Huebner RE, Binkin NJ. Tuberculin reactivity in a pediatric population with high BCG vaccination coverage. Int J Tuberc Lung Dis 1999;3(1):23-30.
37. Kuyucu N, Kuyucu S, Bakirtas A, Karacan C. BCG revaccination and tuberculin reactivity. Indian J Pediatr 2001;68:21-25.
38. Menzies D. What does tuberculin reactivity after Bacille Calmette-Guérin vaccination tell us? Clin Inf Dis 2000;31 (suppl 3):71-4.
39. Suciliene E, Ronne T, Plesner AM, Semenaite B, Slapkauskaite D, Larsen SO, et al. Infant BCG vaccination study in Lithuania. Int J Tuberc Lung Dis 1999;3:956-961.
40. Al Zahrani K, Al Jahdali H, Menzies D. Does size matter? Utility of size of tuberculin reactions for the diagnosis of mycobacterial disease. Am J Respir Crit Care Med 2000;162:1419-1422.
41. Snider DE Jr. Bacille Calmette Guerin vaccinations and tuberculin skin tests. JAMA 1985;253:3438-3439.
42. Brewer TF, Wilson ME, Nardell EA. BCG immunization: review of past experience, current use, and future prospects. Curr Clin Top Infect Dis 1995;15:253-270.
43. Black GF, Dockrell HM, Crampin AC, Floyd S, Weir RE, Bliss L, et al. Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi. J Infect Dis 2001;184(3):322-329.
44. Behr MA, Small PM. A historical and molecular phylogeny of BCG strains. Vaccine 1999;17(7-8):915-922.
45. Vallishayee RS, Shashidhara AN, Bunch-Christensen K, Guld J. Tuberculin sensitivity and skin lesions in children after vaccination with 11 different BCG strains. Bull World Health Organ 1974;51(5):489-494.
46. Junior LP, Filho PP. Comparative immuno-genicity of BCG substrains for mice. Rev Bras Pesqui Med Biol 1979;12(4-5):311-316.
47. Lagranderie MR, Balazuc AM, Deriaud E, Leclerc CD, Gheorghiu M. Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains. Infect Immun 1996;64(1):1-9.
48. Shaaban MA, Abdul Ati M, Bahr GM, Stand-ford JL, Lockwood DN, McManus IC. Revaccination with BCG: its effects on skin tests in Kuwaiti senior school children. Eur Respir J 1990;3(2):187-191.
49. Ildirim I, Hacimustafaoglu M, Ediz B. Correlation of tuberculin induration with the number of Bacillus Calmette-Guerin vaccines. Pediatr Infect Dis J 1995;14:1060-1063.